RT @CampbellMDPhD: Dexrazoxane ⬇️risk of 💔failure/events in patients w breast cancer + anthracycline chemo +/- trastuzumab w/o impacting ca…
RT @CampbellMDPhD: Dexrazoxane ⬇️risk of 💔failure/events in patients w breast cancer + anthracycline chemo +/- trastuzumab w/o impacting ca…
Dexrazoxane ⬇️risk of 💔failure/events in patients w breast cancer + anthracycline chemo +/- trastuzumab w/o impacting cancer outcomes. @md_arianemacedo Article: https://t.co/MzeZxkCesl Editorial: https://t.co/sD2oMXdEfi Another excellent #jaccco paper! #Ca
RT @md_arianemacedo: Inspiring editorial by Dr @DrCESimmons commenting cardioprotective strategies in ANT induced CTX in Breast cancer. T…
RT @NicoleKuderer: #OncoAlert “Overcoming inertia to tame the red devil”. Important editorial by Dr @DrCESimmons commenting on cardioprotec…
RT @md_arianemacedo: Inspiring editorial by Dr @DrCESimmons commenting cardioprotective strategies in ANT induced CTX in Breast cancer. T…
#OncoAlert “Overcoming inertia to tame the red devil”. Important editorial by Dr @DrCESimmons commenting on cardioprotective strategies for anthra induced CTX in #Breastcancer. Congrats @md_arianemacedo & team 👏!
RT @md_arianemacedo: Inspiring editorial by Dr @DrCESimmons commenting cardioprotective strategies in ANT induced CTX in Breast cancer. T…
Inspiring editorial by Dr @DrCESimmons commenting cardioprotective strategies in ANT induced CTX in Breast cancer. Thanks for your great comments about our last paper published today @JACCJournals #JACCOCO https://t.co/hESmaNKJvD